valine and Hyperlipemia

valine has been researched along with Hyperlipemia in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's2 (20.00)18.2507
2000's6 (60.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Palmer, OM; Rhoads, DD; Sivak, RA1
Bandsma, RH; Boer, T; Kuipers, F; Prinsen, BH; Rake, JP; Reijngoud, DJ; Smit, GP; van Der Velden, Mde S1
Akasaka, T; Goto, M; Ikejima, H; Imanishi, T; Kitabata, H; Kuroi, A; Mochizuki, S; Muragaki, Y; Takarada, S; Tanimoto, T; Tsujioka, H; Yoshida, K1
Akasaka, T; Goto, M; Ikejima, H; Imanishi, T; Kobayashi, K; Kuroi, A; Mochizuki, S; Muragaki, Y; Shiomi, M; Tsujioka, A; Tsujioka, H; Yoshida, K1
Li, Z; Liu, J; Luo, CH; Tan, ZR; Wang, A; Wang, LS; Yu, BN; Zhang, W; Zhou, G; Zhou, HH1
Endo, K; Koide, N; Miyashita, Y; Murano, T; Ohira, M; Oyama, T; Saiki, A; Shirai, K1
Glazer, R; Jia, Y; Kariisa, M; Pitt, B; Prescott, MF; Radauceanu, A; Rajagopalan, S; Zannad, F1
Hevia, P; Kari, FW; Ulman, EA; Visek, WJ1
Barrett, HA; de Sain-van der Velden, MG; Gadellaa, MM; Kaysen, GA; Rabelink, TJ; Reijngoud, DJ; Stellaard, F; Voorbij, HA1
Cameron, IM; Gaffney, D; Hoffs, MS; O'Reilly, DS; Packard, CJ; Stewart, G1

Trials

4 trial(s) available for valine and Hyperlipemia

ArticleYear
Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a.
    Pediatric research, 2008, Volume: 63, Issue:6

    Topics: Acetates; Adult; Case-Control Studies; Cholesterol; Female; Glycerol; Glycogen Storage Disease Type I; Humans; Hyperlipidemias; Infusions, Parenteral; Kinetics; Lipogenesis; Lipoproteins, IDL; Lipoproteins, VLDL; Male; Particle Size; Valine

2008
Ile118Val genetic polymorphism of CYP3A4 and its effects on lipid-lowering efficacy of simvastatin in Chinese hyperlipidemic patients.
    European journal of clinical pharmacology, 2005, Volume: 60, Issue:12

    Topics: Adult; Aged; Asian People; China; Cholesterol; Cortisone; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Gene Frequency; Humans; Hydrocortisone; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Isoleucine; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Simvastatin; Triglycerides; Valine

2005
The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension.
    Diabetes research and clinical practice, 2006, Volume: 74, Issue:3

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Diabetes Mellitus, Type 2; Female; Humans; Hyperlipidemias; Hypertension; Lipoprotein Lipase; Lipoproteins; Male; Middle Aged; Tetrazoles; Valine; Valsartan

2006
Effects of valsartan alone versus valsartan/simvastatin combination on ambulatory blood pressure, C-reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertension.
    The American journal of cardiology, 2007, Jul-15, Volume: 100, Issue:2

    Topics: Antihypertensive Agents; Biomarkers; Blood Pressure Monitoring, Ambulatory; C-Reactive Protein; Chemokine CCL2; Double-Blind Method; Drug Combinations; Drug Synergism; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Simvastatin; Tetrazoles; Valine; Valsartan

2007

Other Studies

6 other study(ies) available for valine and Hyperlipemia

ArticleYear
Plasma abnormalities following overdose.
    Clinical chemistry, 2014, Volume: 60, Issue:7

    Topics: Color; Diltiazem; Drug Overdose; Fat Emulsions, Intravenous; Female; Food-Drug Interactions; Hemolysis; Humans; Hyperlipidemias; Middle Aged; Off-Label Use; Plasma; Poisoning; Tetrazoles; Valine; Valsartan

2014
Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 52, Issue:3

    Topics: Acetylcholine; Amides; Animals; Antihypertensive Agents; Atherosclerosis; Biopterins; Blood Pressure; Drug Therapy, Combination; Endothelium, Vascular; Fumarates; Heart Rate; HSP90 Heat-Shock Proteins; Hyperlipidemias; Inflammation Mediators; Lipids; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Proto-Oncogene Proteins c-akt; Rabbits; Renin; Tetrazoles; Tyrosine; Valine; Valsartan; Vasodilation; Vasodilator Agents

2008
Combined effects of an 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor and angiotensin II receptor antagonist on nitric oxide bioavailability and atherosclerotic change in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:6

    Topics: Acetylcholine; Angiotensin II Type 1 Receptor Blockers; Animals; Atherosclerosis; Biological Availability; Drug Therapy, Combination; Echocardiography; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Myocardial Infarction; Nitric Oxide; Quinolines; Rabbits; Reactive Oxygen Species; Tetrazoles; Tyrosine; Valine; Valsartan

2008
Serum lipids of rats fed excess L-lysine and different carbohydrates.
    The Journal of nutrition, 1980, Volume: 110, Issue:6

    Topics: Amino Acids; Animals; Cholesterol; Dietary Carbohydrates; Dose-Response Relationship, Drug; Fatty Liver; Glutamates; Hyperlipidemias; Lipid Metabolism; Lipids; Liver; Lysine; Male; Phospholipids; Rats; Threonine; Triglycerides; Valine

1980
Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis.
    Kidney international, 1998, Volume: 53, Issue:4

    Topics: Adult; Apolipoprotein A-I; Apolipoprotein B-100; Apolipoproteins B; Carbon Isotopes; Cholesterol, LDL; Cholesterol, VLDL; Female; Humans; Hyperlipidemias; Male; Middle Aged; Nephrotic Syndrome; Proteinuria; Serum Albumin; Valine

1998
Influence of polymorphism Q3405E and mutation A3371V in the apolipoprotein B gene on LDL receptor binding.
    Atherosclerosis, 1998, Volume: 137, Issue:1

    Topics: Adult; Aged; Alanine; Amino Acid Substitution; Apolipoproteins B; DNA; DNA Mutational Analysis; Family; Family Health; Female; Gene Frequency; Glutamic Acid; Glutamine; Haplotypes; Humans; Hyperlipidemias; Leucine; Lipoproteins, LDL; Male; Middle Aged; Point Mutation; Polymorphism, Genetic; Protein Binding; Receptors, LDL; Valine

1998